menu
    • menu

    Company profile for Osteal Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Osteal Therapeutics® is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.The lead product under development, VT-X7, is a drug-device combination product that has the potential to be the first FDA approved antibiotic therapy for local delivery to treat infected joint prosthesis. If approved, VT-X7 has the potential to imp...
    Osteal Therapeutics® is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.The lead product under development, VT-X7, is a drug-device combination product that has the potential to be the first FDA approved antibiotic therapy for local delivery to treat infected joint prosthesis. If approved, VT-X7 has the potential to improve outcomes and lower the cost of care for orthopedic surgeons and their patients by providing a faster, more reliable treatment option.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Osteal TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4835 Lyndon B. Johnson Freeway, Suite 635, Dallas, TX 75244
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ostealtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/osteal/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Osteal Therapeutics Announces Positive APEX Trial Results
    Osteal Therapeutics Announces Positive APEX Trial Results

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981677/0/en/Osteal-Therapeutics-Announces-Positive-12-Month-Results-from-the-APEX-Clinical-Trial-Program-at-the-2024-American-Association-of-Hip-and-Knee-Surgeons-AAHKS-Annual-Meeting.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Osteal Therapeutics Presents APEX Trial Results At MSIS Meeting
    Osteal Therapeutics Presents APEX Trial Results At MSIS Meeting

    05 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/05/2924503/0/en/Osteal-Therapeutics-Presents-Positive-Six-Month-Results-from-the-APEX-Clinical-Trial-Program-at-the-34th-Annual-Musculoskeletal-Infection-Society-Meeting.html

    GLOBENEWSWIRE
    05 Aug 2024
    Share Share
    Osteal raises $50m to bring joint infection drug/device combo to market
    Osteal raises $50m to bring joint infection drug/device combo to market

    06 Jun 2024

    // Robert Barrie PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/osteal-raises-50m-to-bring-joint-infection-drug-device-combo-to-market/

    Robert Barrie PHARMACEUTICAL TECHNOLOGY
    06 Jun 2024
    Share Share
    Glucotrack: Implant Sustained Accuracy In 90-Day Preclinical Study
    Glucotrack: Implant Sustained Accuracy In 90-Day Preclinical Study

    05 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/05/2893897/0/en/Osteal-Therapeutics-Closes-50M-Series-D-Financing-to-Support-Approval-and-Commercial-Launch-of-Lead-Candidate.html

    GLOBENEWSWIRE
    05 Jun 2024
    Share Share
    Osteal Therapeutics VT-X7 Receives FDA Breakthrough Therapy Designation
    Osteal Therapeutics VT-X7 Receives FDA Breakthrough Therapy Designation

    05 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/12/05/2790778/0/en/Osteal-Therapeutics-VT-X7-Receives-FDA-s-Breakthrough-Therapy-Designation-for-the-treatment-of-periprosthetic-joint-infection-of-the-hip-and-knee-and-completes-enrollment-of-the-pi.html

    GLOBENEWSWIRE
    05 Dec 2023
    Share Share
    BioNTX Names Osteal Therapeutics 2023 Rising Star
    BioNTX Names Osteal Therapeutics 2023 Rising Star

    28 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/28/2751084/0/en/BioNTX-Names-Osteal-Therapeutics-2023-Rising-Star.html

    GLOBENEWSWIRE
    28 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search